Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis

Abstract Research on neuronal and astroglial markers for predicting outcomes in aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorders (NMOSD) remains limited. We aimed to evaluate the prognostic value of blood biomarkers for neuronal and astroglial damage in NMOSD compared with m...

Full description

Saved in:
Bibliographic Details
Main Authors: Wangyong Shin, Eun-Jae Lee, Dayoung Seo, Bum Joon Choi, Inhye Jang, Jin Hee Kim, Lynkyung Choi, Keonwoo Kim, Ji-Yon Kim, Hee-Jae Jung, Hyemi Lee, Hyunjin Kim, Young-Min Lim
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-95773-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849735009843281920
author Wangyong Shin
Eun-Jae Lee
Dayoung Seo
Bum Joon Choi
Inhye Jang
Jin Hee Kim
Lynkyung Choi
Keonwoo Kim
Ji-Yon Kim
Hee-Jae Jung
Hyemi Lee
Hyunjin Kim
Young-Min Lim
author_facet Wangyong Shin
Eun-Jae Lee
Dayoung Seo
Bum Joon Choi
Inhye Jang
Jin Hee Kim
Lynkyung Choi
Keonwoo Kim
Ji-Yon Kim
Hee-Jae Jung
Hyemi Lee
Hyunjin Kim
Young-Min Lim
author_sort Wangyong Shin
collection DOAJ
description Abstract Research on neuronal and astroglial markers for predicting outcomes in aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorders (NMOSD) remains limited. We aimed to evaluate the prognostic value of blood biomarkers for neuronal and astroglial damage in NMOSD compared with multiple sclerosis (MS). Patients with NMOSD and MS were prospectively recruited, and baseline serum levels of neurofilament light (sNfL) and glial fibrillary acidic protein (sGFAP) were measured. The correlations between these biomarkers and neurological disability (Expanded Disability Status Scale, EDSS) and cognitive function (iPad-based processing speed test, PST) were analyzed at baseline and two years later. In this cohort of 41 NMOSD and 92 MS patients, blood biomarkers demonstrated distinct patterns of association with current and future outcomes. In NMOSD, sGFAP was consistently linked to neurological disability and cognitive impairment over time, reflecting astrocytopathy with minimal silent neurodegeneration. In MS, sGFAP did not correlate with baseline EDSS but showed associations with future scores. Notably, sNfL was more strongly associated with future PST scores than baseline scores (p = 0.005), suggesting ongoing neurodegeneration. These results underscore that blood biomarkers are predictive of both current and future outcomes in NMOSD and MS, with differing patterns reflecting the unique pathogenesis of each disease.
format Article
id doaj-art-1d685d76886f49558b3ca170db25edb6
institution DOAJ
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1d685d76886f49558b3ca170db25edb62025-08-20T03:07:40ZengNature PortfolioScientific Reports2045-23222025-04-0115111010.1038/s41598-025-95773-6Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosisWangyong Shin0Eun-Jae Lee1Dayoung Seo2Bum Joon Choi3Inhye Jang4Jin Hee Kim5Lynkyung Choi6Keonwoo Kim7Ji-Yon Kim8Hee-Jae Jung9Hyemi Lee10Hyunjin Kim11Young-Min Lim12Department of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Medicine, Asan Medical Institute of Convergence Science and Technology, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Neurology, Asan Medical Center, University of Ulsan College of MedicineAbstract Research on neuronal and astroglial markers for predicting outcomes in aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorders (NMOSD) remains limited. We aimed to evaluate the prognostic value of blood biomarkers for neuronal and astroglial damage in NMOSD compared with multiple sclerosis (MS). Patients with NMOSD and MS were prospectively recruited, and baseline serum levels of neurofilament light (sNfL) and glial fibrillary acidic protein (sGFAP) were measured. The correlations between these biomarkers and neurological disability (Expanded Disability Status Scale, EDSS) and cognitive function (iPad-based processing speed test, PST) were analyzed at baseline and two years later. In this cohort of 41 NMOSD and 92 MS patients, blood biomarkers demonstrated distinct patterns of association with current and future outcomes. In NMOSD, sGFAP was consistently linked to neurological disability and cognitive impairment over time, reflecting astrocytopathy with minimal silent neurodegeneration. In MS, sGFAP did not correlate with baseline EDSS but showed associations with future scores. Notably, sNfL was more strongly associated with future PST scores than baseline scores (p = 0.005), suggesting ongoing neurodegeneration. These results underscore that blood biomarkers are predictive of both current and future outcomes in NMOSD and MS, with differing patterns reflecting the unique pathogenesis of each disease.https://doi.org/10.1038/s41598-025-95773-6Neuromyelitis Optica spectrum disorderMultiple sclerosisBiomarkersNeurofilament lightGlial fibrillary acidic protein
spellingShingle Wangyong Shin
Eun-Jae Lee
Dayoung Seo
Bum Joon Choi
Inhye Jang
Jin Hee Kim
Lynkyung Choi
Keonwoo Kim
Ji-Yon Kim
Hee-Jae Jung
Hyemi Lee
Hyunjin Kim
Young-Min Lim
Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
Scientific Reports
Neuromyelitis Optica spectrum disorder
Multiple sclerosis
Biomarkers
Neurofilament light
Glial fibrillary acidic protein
title Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
title_full Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
title_fullStr Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
title_full_unstemmed Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
title_short Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
title_sort distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
topic Neuromyelitis Optica spectrum disorder
Multiple sclerosis
Biomarkers
Neurofilament light
Glial fibrillary acidic protein
url https://doi.org/10.1038/s41598-025-95773-6
work_keys_str_mv AT wangyongshin distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT eunjaelee distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT dayoungseo distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT bumjoonchoi distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT inhyejang distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT jinheekim distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT lynkyungchoi distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT keonwookim distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT jiyonkim distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT heejaejung distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT hyemilee distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT hyunjinkim distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis
AT youngminlim distinctprognosticimplicationsofbloodneuronalandastroglialbiomarkersinneuromyelitisopticaspectrumdisordersversusmultiplesclerosis